Microsecretory Adenocarcinoma of the Ear Canal: Novel Cutaneous Analog of a Salivary Gland Neoplasm

Am J Dermatopathol. 2022 Nov 1;44(11):855-858. doi: 10.1097/DAD.0000000000002270. Epub 2022 Jul 28.

Abstract

Microsecretory adenocarcinoma (MSA) of the salivary gland is a new entity recently added to the World Health Organization Classification of Head and Neck Tumors. This tumor is characterized by a recurrent MEF2C-SS18 translocation. We present a nodular tumor confined to the dermis of the ear canal of a 44-year-old patient, which demonstrated classic histopathologic features and molecular alteration of MSA. Specifically, the tumor was composed of numerous tubules and microcysts filled with abundant basophilic mucinous secretion and associated with a fibromyxoid stroma. The tumor cells were diffusely positive for CK7 and SOX10 and variably positive for S100 and p63. Breakapart fluorescence in situ hybridization for SS18 confirmed rearrangement of this gene. Together, these findings support a primary cutaneous MSA, presumably arising from ceruminous glands of the ear canal. Based on current knowledge of its salivary gland counterpart, cutaneous MSA is expected to be locally invasive but unlikely to recur or metastasize on complete excision.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / genetics
  • Adenocarcinoma* / surgery
  • Adult
  • Biomarkers, Tumor / genetics
  • Ear Canal / pathology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Neoplasm Recurrence, Local
  • Salivary Gland Neoplasms* / genetics
  • Salivary Gland Neoplasms* / pathology

Substances

  • Biomarkers, Tumor